Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment
Drekonja DM, Shaukat A, Zhang JH, Reinink AR, Nugent S, Dominitz JA, Davis-Karim A, Gerding DN, Kyriakides TC. Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment. Clinical Trials 2021, 18: 622-629. PMID: 34154439, DOI: 10.1177/17407745211021198.Peer-Reviewed Original ResearchConceptsClinical trialsCase identificationRecurrent infectionsIndividuals meeting inclusion criteriaVeterans Affairs Corporate Data WarehouseFrequent antimicrobial usePrevention of recurrentRecurrent Clostridioides difficileSuccessful initial treatmentFecal microbiota transplantationIncidence of recurrentVeterans Affairs systemFecal microbiota transplantNationwide clinical trialMeeting inclusion criteriaQuality of lifeCorporate Data WarehouseTransplant administrationPrimary endpointStandard therapySubstantial morbidityInitial treatmentCapsule administrationMicrobiota transplantationRandomized comparison